SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-026620
Filing Date
2021-11-15
Accepted
2021-11-15 07:56:51
Documents
80
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q urgn20210930_10q.htm   iXBRL 10-Q 1522050
2 EXHIBIT 31.1 ex_283901.htm EX-31.1 17008
3 EXHIBIT 31.2 ex_283902.htm EX-31.2 17017
4 EXHIBIT 32.1 ex_283903.htm EX-32.1 6573
5 EXHIBIT 32.2 ex_283904.htm EX-32.2 6587
  Complete submission text file 0001437749-21-026620.txt   5834467

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA urgn-20210930.xsd EX-101.SCH 62927
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20210930_cal.xml EX-101.CAL 45418
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20210930_def.xml EX-101.DEF 338989
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20210930_lab.xml EX-101.LAB 290560
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20210930_pre.xml EX-101.PRE 374719
11 EXTRACTED XBRL INSTANCE DOCUMENT urgn20210930_10q_htm.xml XML 766077
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 211406409
SIC: 2834 Pharmaceutical Preparations